Synchronyx: New Evidence Shows 72% of Medication Adherence Risk Is Invisible to Refill Data
Cross-therapy real-world evidence shows medication adherence barriers surface in the first 30 days — weeks before refill-based monitoring can detect them. BALTIMORE, MD, UNITED STATES, May 14, 2026 /EINPresswire.com/ -- Synchronyx, the …